Targeting Kindlin-2 in adipocytes increases bone mass through inhibiting FAS/PPAR<i>γ</i>/FABP4 signaling in mice.
Journal Information
Full Title: Acta Pharm Sin B
Abbreviation: Acta Pharm Sin B
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pharmacology & Pharmacy
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of interest The corresponding authors Huiling Cao and Guixing Ma have filed a patent application (202210877899. X) for the treatment of OP. The other authors declare no conflicts of interests."
"We acknowledge the assistance of Core Research Facilities of Southern University of Science and Technology. Support of this work partially came from 10.13039/100014717National Natural Science Foundation of China Grants (82022047 and 81972100), the 10.13039/501100012166National Key Research and Development Program of China Grants (2019YFA0906001), Guangdong Provincial Science and Technology Innovation Council Grant (2017B030301018, China)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025